SHORT MINI-FUTURE - AMGEN | Market Closed - Deutsche Boerse AG 01:42:27 2024-05-17 pm EDT | ||
| 7.11 EUR | +0.71% |
|
| Current month | -35.89% | ||
| 1 month | -40.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 7.11 | +0.71% |
| 24-05-16 | 7.06 | +4.44% |
| 24-05-15 | 6.76 | -12.66% |
| 24-05-14 | 7.74 | -1.78% |
| 24-05-13 | 7.88 | +5.21% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 01:42 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM9NYS |
| ISIN | DE000VM9NYS4 |
| Date issued | 2024-02-02 |
| Strike | 390.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.24 € |
|---|---|
| Lowest since issue | 6.21 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
